Antipsychotic drug treatment for elderly people with late-onset schizophrenia
Authors:
- 15 February 2012
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2013 (2) , CD004162
Abstract
Background Schizophrenia is usually considered an illness of young adulthood. However, onset after the age of 40 years is reported in 23% of patients hospitalised with schizophrenia. At least 0.1% of the world's elderly population have a diagnosis of late-onset schizophrenia which seems to differ from earlier onset schizophrenia on a variety of counts including response to antipsychotic drugs. Objectives To assess the effects of antipsychotic drugs for elderly people with late-onset schizophrenia. Search methods We searched the Cochrane Schizophrenia Group Trials Register (January 2010) which is based on regular searches of CINAHL, EMBASE, MEDLINE and PsycINFO. We inspected references of all identified studies for further trials. We contacted relevant authors of trials for additional information. Selection criteria All relevant randomised controlled trials that compared antipsychotic drugs with other treatments for elderly people (at least 80% older than 65 years) with a recent (within five years) diagnosis of schizophrenia or schizophrenia like illnesses. Data collection and analysis For the 2010 search, two new review authors (AE, AG) inspected all citations to ensure reliable selection. We assessed methodological quality of trials using the criteria recommended in the Cochrane Handbook for Systematic Reviews of Interventions. AE and AG also independently extracted data. For homogenous dichotomous data, we planned to calculate the relative risk (RR) and 95% confidence interval (CI). Main results There were no included studies in the original version of this review (2002 search). The 2010 search for the current update produced 211 references, among which we identified 88 studies. Only one study met the inclusion criteria and was of acceptable quality. This was an eight-week randomised trial of risperidone and olanzapine in 44 inpatients with late-onset schizophrenia. All participants completed the eight-week trial, indicating that both drugs were well tolerated. Unfortunately, this study provided little usable data. We excluded a total of 81 studies, 77 studies because they either studied interventions other than antipsychotic medication or because they involved elderly people with chronic - not late-onset - schizophrenia. We excluded a further four trials of antipsychotics in late-onset schizophrenia because of flawed design. Five studies are still awaiting classification, and one is on-going. Authors' conclusions There is no trial-based evidence upon which to base guidelines for the treatment of late-onset schizophrenia. There is a need for good quality-controlled clinical trials into the effects of antipsychotics for this group. Such trials are possible. Until they are undertaken, people with late-onset schizophrenia will be treated by doctors using clinical judgement and habit to guide prescribing.Keywords
This publication has 200 references indexed in Scilit:
- Results of phase 3 of the CATIE schizophrenia trialSchizophrenia Research, 2009
- The impact of obesity on health care costs among persons with schizophreniaGeneral Hospital Psychiatry, 2009
- Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia studySchizophrenia Research, 2008
- Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Schizophrenia Research, 2008
- Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic SchizophreniaSchizophrenia Bulletin, 2008
- Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophreniaSchizophrenia Research, 2008
- Supported Employment for Middle-Aged and Older People with SchizophreniaAmerican Journal of Psychiatric Rehabilitation, 2008
- RETRACTED ARTICLE: Individual Placement and Support in Europe: The EQOLISE trialInternational Review of Psychiatry, 2008
- Reducing emergency medical service use in patients with chronic psychotic disorders: Results from the FAST intervention studyBehaviour Research and Therapy, 2008
- Antipsychotic Medications and the ElderlyDrugs & Aging, 2001